EMMAC, in which FFWD owns a 2.4% stake, said Medican has already processed over 100 medical cannabis prescriptions in the UK and will be able to leverage EMMAC’s vertically integrated supply chain to create value for clients.
READ: FastForward Innovations investee company becomes the first supplier to export medical cannabis to Israel
Medican is a division of EMMAC’s subsidiary, Rokshaw, a registered pharmacy that is licenced to import, manufacture and securely deliver medical cannabis products to UK patients.
“We believe our [Medicines and Healthcare products Regulatory Agency]-approved medical cannabis manufacturing facility, combined with our experienced team of on-site pharmacists and health care professionals will provide an important service for the growing number of patients requiring medical cannabis", said EMMAC managing director Ed McDermott.
FastForward shares were steady at 7.2p in early trading on Tuesday.
--Adds share price--